HOME Top Market Reports Patient Monitoring Devices Market (Equipments & Systems) (2011 - 2016) - Global Trends, End-user & Value-Volume Analysis

Patient Monitoring Devices Market (Equipments & Systems) (2011 - 2016) - Global Trends, End-user & Value-Volume Analysis

By: marketsandmarkets.com
Publishing Date: April 2012
Report Code: MD 1143

Discount on Reports  

Enquiry Before Buying
Analyst Briefing  
purchase report
download pdf  request for customisation


"Patient Monitoring Devices / Equipments / Systems Market (2011 - 2016) (Remote Patient Monitoring, Blood Pressure, Blood Glucose, EEG, ECG, Sleep Apnea, Pulse Oximeter, Spirometer, Multi-Parameter, Fetal & Neonatal, Temperature, Weight) - Global Trends, End-user & Value-Volume Analysis"

The patient monitoring devices market consists of segments like hemodynamic, neurology, cardiac, respiratory, fetal and neonatal, multi-parameter, remote patient monitors and temperature & weight management monitors. The global devices market for patient monitoring was valued at $14.2 billion in 2011 and is poised to grow at a CAGR of 5.9% from 2011 to 2016 to reach $18.9 billion.

The market will be driven by increasing aging population, rising incidences of lifestyle diseases, home and remote monitors and increasing portability of equipments. However, the economic slowdown and unstable reimbursement policies will restrict the growth of this market to a certain extent.

North America is the biggest market, followed by Europe however, the Asian countries represent the fastest growing markets due to large population and increased purchasing power of patients. Moreover, economic slowdown in western countries will compel the companies to focus on the Asian markets.

As end-users, hospitals occupy a share of more than half the share in the patient monitoring devices market, followed by home monitoring. By 2016, hospitals will lose some share to home monitors owing to the fact that demand for home monitoring is increasing and strict government policies are being implemented to reduce patient stay in hospitals.

The major players in this market are CareFusion (U.S.), Covidien (Ireland), Draeger Medical (Switzerland), GE Healthcare (UK), Masimo (U.S.), MindRay Medical (China), Nihon Kohden (Japan), Omron Healthcare (Japan), Philips Healthcare (The Netherlands), Schiller AG (Switzerland) and Welch Allyn (U.S.).

Scope of the repot

Market, by segments:

  • Hemodynamic monitoring devices
    • Blood glucose
    • Blood pressure
    • Blood cholesterol
    • Blood gas monitors
  • Neuromonitoring devices
    • Electroencephalograph (EEG)
    • Transcranial Dopplers (TCD)
    • Magnetoencephalograph (MEG)
  • Cardiac monitoring devices
    • Electrocardiogram (ECG / EKG)
    • Cardiac output monitors
  • Fetal and neonatal monitors
    • Ultrasound fetal Dopplers
    • Internal fetal monitors
    • Intrauterine pressure catheters
  • Respiratory monitors
    • Capnographs
    • Spirometers
    • Anesthesia monitors
    • Pulse oximeters
    • Sleep apnea monitors
  • Multi-parameter monitoring devices
    • Low acuity
    • Mid acuity
    • High acuity
  • Remote patient monitoring devices
  • Temperature and weight monitors

Market, by end-users:

  • Hospitals
  • Home
  • Others (research and diagnostic centers)

Market, by geography:

  • North America
  • Europe
  • APAC
  • ROW

The report does not include services and accessories market for patient monitoring devices.

TABLE OF CONTENTS

1 INTRODUCTION
  1.1 KEY TAKE-AWAYS
  1.2 REPORT DESCRIPTION
  1.3 MARKETS COVERED
  1.4 STAKEHOLDERS
  1.5 RESEARCH METHODOLOGY
      1.5.1 MARKET SIZE
      1.5.2 MARKET SHARE
      1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
      1.5.4 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
  3.1 INTRODUCTION
  3.2 MARKET DYNAMICS
      3.2.1 DRIVERS
            3.2.1.1 Increasing geriatric population to propel need of monitoring devices
            3.2.1.2 Increasing incidences of lifestyle diseases is projected to fuel need of patient monitoring devices
            3.2.1.3 Home & remote monitoring, an essential factor driving market of patient monitoring
            3.2.1.4 Ease-of-use & portability of devices to push Point-of-Care monitoring devices
      3.2.2 RESTRAINTS
            3.2.2.1 Economic downturn & saturation to slow growth of monitoring devices market
            3.2.2.2 Unstable reimbursement regulations to restrict growth in Patient Monitoring Market
      3.2.3 OPPORTUNITIES
            3.2.3.1 Private institutional nursing
            3.2.3.2 M&A and Joint Ventures
  3.3 MARKET SEGMENTATION
  3.4 MARKET SHARE ANALYSIS
      3.4.1 MARKET SHARE ANALYSIS OF KEY PLAYERS
      3.4.2 HEMODYNAMIC MONITOR
            3.4.2.1 Blood pressure monitor
            3.4.2.2 Single point blood glucose monitor
            3.4.2.3 Continuous blood glucose monitor
            3.4.2.4 Blood gas analyzers
      3.4.3 NEUROMONITOR
            3.4.3.1 EEG
            3.4.3.2 TCD
            3.4.3.3 MEG
      3.4.4 CARDIAC MONITOR
            3.4.4.1 ECG
      3.4.5 RESPIRATORY MONITOR
            3.4.5.1 Capnograph
            3.4.5.2 Spirometer
            3.4.5.3 Anesthesia monitor
            3.4.5.4 Sleep apnea monitor
            3.4.5.5 Pulse oximeter
      3.4.6 FETAL & NEONATAL
      3.4.7 MULTI-PARAMETER
      3.4.8 REMOTE PATIENT MONITORING DEVICES
  3.5 END-USER ANALYSIS

4 HEMODYNAMIC MONITORING DEVICES
  4.1 INTRODUCTION
  4.2 DRIVERS & OPPORTUNITIES
      4.2.1 INCREASE OF HYPERTENSION CASES
      4.2.2 INCREASE IN DIABETIC POPULATION
      4.2.3 NON-INVASIVE DEVICES
      4.2.4 INCREASING POPULATION OPTING FOR SELF-MONITORING DEVICES
  4.3 RESTRAINT
      4.3.1 HIGH FRAGMENTATION IN COMPETITORS FOR HEMODYNAMIC MONITORING DEVICES
  4.4 BLOOD PRESSURE MONITORING DEVICES
  4.5 BLOOD GLUCOSE MONITORING DEVICES
      4.5.1 MARKET DYNAMICS
            4.5.1.1 Advancing technology
            4.5.1.2 Decreasing value of blood glucose kits to reduce market size & restrain growth
            4.5.1.3 Untapped potential present in large population of undiagnosed diabetics
  4.6 BLOOD GAS ANALYZERS/MONITORS
      4.6.1 DRIVERS & RESTRAINTS
            4.6.1.1 Inadequacy of alternate techniques provides stable growth for invasive blood gas analyzers
            4.6.1.2 Complex operation & interpretation restricts use of these devices & reduces growth of market
  4.7 CHOLESTEROL MONITORING DEVICES

5 NEUROLOGICAL MONITORING DEVICES
  5.1 INTRODUCTION
  5.2 DRIVERS
      5.2.1 INCREASING INCIDENCES OF NEURO-DEGENERATIVE DISEASES, A MAJOR DRIVER FOR NEUROMONITORING DEVICES
      5.2.2 RISING AWARENESS & EXPOSURE TO LITERATURE OF NEURO-DEGENERATIVE DISEASES
      5.2.3 ADVANCED TECHNOLOGY
      5.2.4 MONITORING FOR INVALIDS & INFANTS TO DRIVE NEUROMONITORING ALONG WITH OTHER RESEARCH
  5.3 RESTRAINTS
      5.3.1 DIFFICULTY IN EARLY DETECTION
      5.3.2 COMPLEX INTERPRETATION RESTRICTS USE OF THESE DEVICES & SLOWS GROWTH
  5.4 OPPORTUNITIES
      5.4.1 TELEMETRIC NEUROMONITORING SHOW ADVANCED OPTIONS IN NEUROMONITORING
  5.5 ELECTROENCEPHALOGRAPH (EEG)
  5.6 TRANSCRANIAL DOPPLER (TCD)
  5.7 MAGNETOENCEPHALOGRAPH (MEG)
  5.8 INTRACRANIAL PRESSURE MONITORS (ICP)
  5.9 CEREBRAL OXIMETER

6 CARDIAC MONITORING DEVICES
  6.1 INTRODUCTION
  6.2 DRIVERS & OPPORTUNITY
      6.2.1 INCREASING INCIDENCES OF CARDIOVASCULAR DISEASES, A PRIMARY DRIVER
      6.2.2 RISE IN COST OF HEART DISEASE TREATMENT WILL PUSH MARKET GROWTH FOR MONITORING
      6.2.3 ECG DATA MANAGEMENT SYSTEMS, A RISING OPPORTUNITY
  6.3 ECG/EKG DEVICES
      6.3.1 MARKET DYNAMICS
            6.3.1.1 Increasing incidence of CVD to boost the growth of ECG monitors
            6.3.1.2 Technological advances to drive the growth of ECG telemetry devices
            6.3.1.3 Asian region improves the growth prospects
            6.3.1.4 Market maturity
  6.4 CARDIAC OUTPUT MONITORING DEVICES

7 FETAL & NEONATAL MONITORING DEVICES
  7.1 INTRODUCTION
  7.2 DRIVERS & OPPORTUNITIES
      7.2.1 HIGH NUMBER OF PRETERM BIRTHS
      7.2.2 INCREASED RATE OF PREGNANCY
      7.2.3 INCREASED ACCESS TO PREGNANCY INFORMATION
      7.2.4 LOWERING COST FOR BUYING AND RENTING MONITORING EQUIPMENT WILL INCREASE USE OF FETAL & NEONATAL MONITORS
      7.2.5 PORTABLE & WIRELESS DOPPLER
  7.3 RESTRAINTS
      7.3.1 GOVERNMENT REGULATIONS RESTRICT SALE OF FETAL MONITORING DEVICES

8 RESPIRATORY MONITORING DEVICES
  8.1 INTRODUCTION
  8.2 DRIVERS
      8.2.1 RISING FOCUS ON MONITORING RESPIRATORY DISEASES
      8.2.2 INCREASING INCIDENCES OF RESPIRATORY DISEASES
      8.2.3 GOVERNMENT REGULATIONS
      8.2.4 POLLUTION, HABITUAL SMOKING HAS INCREASED THE DRIVE FOR RESPIRATORY MONITORING DEVICES
  8.3 CAPNOGRAPHS
      8.3.1 DRIVER & RESTRAINT
            8.3.1.1 Alternate uses
            8.3.1.2 Market maturity & saturation to slow the growth of respiratory monitors
  8.4 SPIROMETER DEVICES
  8.5 ANESTHESIA MONITORS
  8.6 SLEEP APNEA MONITORING DEVICES
      8.6.1 DRIVER
            8.6.1.1 Increasing incidence of obstructive sleep apnea (OSA)
  8.7 PULSE OXIMETERS
      8.7.1 DRIVER & RESTRAINT
            8.7.1.1 Adoption of new technology & increase in the awareness to propel the growth
            8.7.1.2 Multi-parameter integration to restrain stand-alone device market

9 MULTI-PARAMETER MONITORING DEVICES
  9.1 INTRODUCTION
  9.2 DRIVERS & OPPORTUNITIES
      9.2.1 INCREASING NUMBER OF HOSPITALIZATIONS THROUGHOUT THE WORLD TO DRIVE THE MULTI-PARAMETER MARKET
      9.2.2 REMOTE MONITORING AND HOME MONITORING TO DRIVE MID-ACUITY AND LOW-ACUITY SEGMENT
      9.2.3 WIRELESS AND PORTABLE MONITORS MARKET - A NEW OPPORTUNITY

10 REMOTE MARKET PATIENT MONITORING
  10.1 INTRODUCTION
  10.2 DRIVERS & RESTRAINT
      10.2.1 GOVERNMENT REGULATIONS TO CURB HEALTHCARE COSTS
      10.2.2 AGING POPULATION
      10.2.3 TECHNOLOGICAL ADVANCES
      10.2.4 HEALTH CARE CONSUMERISM PATTERN
      10.2.5 COST OF REMOTE PATIENT MONITORING DEVICES, A RESTRAINT
  10.3 OPPORTUNITIES
      10.3.1 NASCENT STAGE OF MARKET
      10.3.2 MERGERS, ACQUISITIONS, JOINT VENTURES & COLLABORATIONS OPPORTUNITIES

11 OTHER MONITORS (WEIGHT & TEMPERATURE)
  11.1 INTRODUCTION
  11.2 WEIGHT MONITORING DEVICES
  11.3 RESTRAINT
  11.3.1 HIGHLY SATURATED & MATURED MARKET REDUCES SCOPE FOR GROWTH & PROFIT
  11.4 TEMPERATURE MONITORING DEVICES
      11.4.1 DRIVERS
            11.4.1.1 Rising number of health conscious consumers driving the market
            11.4.1.2 Technological innovations to boost the market growth

12 GEOGRAPHIC ANALYSIS
  12.1 OVERVIEW
  12.2 NORTH AMERICA
  12.3 EUROPE
  12.4 ASIA-PACIFIC
  12.5 REST OF THE WORLD (ROW)

13 COMPETITIVE LANDSCAPE
  13.1 INTRODUCTION
  13.2 MERGERS & ACQUISITIONS
  13.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
  13.4 NEW PRODUCTS LAUNCH
  13.5 OTHER DEVELOPMENTS

14 COMPANY PROFILES
  14.1 A&D COMPANY LTD
      14.1.1 OVERVIEW
      14.1.2 PRODUCTS & SERVICES
      14.1.3 FINANCIALS
      14.1.4 STRATEGY
      14.1.5 DEVELOPMENTS
  14.2 ABBOTT LABORATORIES
      14.2.1 OVERVIEW
      14.2.2 PRODUCTS & SERVICES
      14.2.3 FINANCIALS
      14.2.4 STRATEGY
      14.2.5 DEVELOPMENTS
  14.3 AMBU INC.
      14.3.1 OVERVIEW
      14.3.2 PRODUCTS & SERVICES
      14.3.3 FINANCIALS
      14.3.4 STRATEGY
      14.3.5 DEVELOPMENTS
  14.4 BRIGGS MEDICAL SERVICE COMPANY
      14.4.1 OVERVIEW
      14.4.2 PRODUCTS & SERVICES
      14.4.3 FINANCIALS
      14.4.4 STRATEGY
      14.4.5 DEVELOPMENTS
  14.5 CARDIOCOM LLC
      14.5.1 OVERVIEW
      14.5.2 PRODUCTS & SERVICES
      14.5.3 FINANCIALS
      14.5.4 STRATEGY
      14.5.5 DEVELOPMENTS
  14.6 CARDIONET INC.
      14.6.1 OVERVIEW
      14.6.2 PRODUCTS & SERVICES
      14.6.3 FINANCIALS
      14.6.4 STRATEGY
      14.6.5 DEVELOPMENTS
  14.7 CAREFUSION CORPORATION
      14.7.1 OVERVIEW
      14.7.2 PRODUCTS & SERVICES
      14.7.3 FINANCIALS
      14.7.4 STRATEGY
      14.7.5 DEVELOPMENTS
  14.8 COMPUMEDICS
      14.8.1 OVERVIEW
      14.8.2 PRODUCTS & SERVICES
      14.8.3 FINANCIALS
      14.8.4 STRATEGY
      14.8.5 DEVELOPMENTS
  14.9 CONMED
      14.9.1 OVERVIEW
      14.9.2 PRODUCTS & SERVICES
      14.9.3 FINANCIALS
      14.9.4 STRATEGY
      14.9.5 DEVELOPMENT
  14.01 CONTEC MEDICAL SYSTEMS CO. LTD.
      14.10.1 OVERVIEW
      14.10.2 PRODUCTS & SERVICES
      14.10.3 FINANCIALS
      14.10.4 STRATEGY
      14.11 COVIDIEN
      14.11.1 OVERVIEW
      14.11.2 PRODUCTS & SERVICES
      14.11.3 FINANCIALS
      14.11.4 STRATEGY
      14.11.5 DEVELOPMENTS
  14.12 DRAEGER MEDICAL GMBH
      14.12.1 OVERVIEW
      14.12.2 PRODUCTS & SERVICES
      14.12.3 FINANCIALS
      14.12.4 DEVELOPMENTS
  14.13 EDWARDS LIFESCIENCES
      14.13.1 OVERVIEW
      14.13.2 PRODUCTS & SERVICES
      14.13.3 FINANCIALS
      14.13.4 STRATEGY
      14.13.5 DEVELOPMENTS
  14.14 ELEKTA
      14.14.1 OVERVIEW
      14.14.2 PRODUCTS & SERVICES
      14.14.3 FINANCIALS
      14.14.4 STRATEGY
      14.14.5 DEVELOPMENTS
  14.15 FISHER & PAYKEL HEALTHCARE LTD
      14.15.1 OVERVIEW
      14.15.2 PRODUCTS & SERVICES
      14.15.3 FINANCIALS
      14.15.4 STRATEGY
  14.16 FUKUDA DENSHI COMPANY LTD.
      14.16.1 OVERVIEW
      14.16.2 PRODUCTS & SERVICES
      14.16.3 FINANCIALS
      14.16.4 STRATEGY
      14.16.5 DEVELOPMENTS
  14.17 GE HEALTHCARE
      14.17.1 OVERVIEW
      14.17.2 PRODUCTS & SERVICES
      14.17.3 FINANCIALS
      14.17.4 STRATEGY
      14.17.5 DEVELOPMENTS
  14.18 HONEYWELL INTERNATIONAL INC.
      14.18.1 OVERVIEW
      14.18.2 PRODUCTS & SERVICES
      14.18.3 FINANCIALS
      14.18.4 STRATEGY
      14.18.5 DEVELOPMENTS
  14.19 INTOUCH HEALTH
      14.19.1 OVERVIEW
      14.19.2 PRODUCTS & SERVICES
      14.19.3 FINANCIALS
      14.19.4 STRATEGY
      14.19.5 DEVELOPMENTS
  14.20 JOHNSON & JOHNSON INC.
      14.20.1 OVERVIEW
      14.20.2 PRODUCTS & SERVICES
      14.20.3 FINANCIALS
      14.20.4 STRATEGY
      14.20.5 DEVELOPMENTS
  14.21 LARSEN & TOUBRO LIMITED (L&T LTD)
      14.21.1 OVERVIEW
      14.21.2 PRODUCTS & SERVICES
      14.21.3 FINANCIALS
      14.21.4 STRATEGY
      14.21.5 DEVELOPMENTS
  14.22 LIFEWATCH AG
      14.22.1 OVERVIEW
      14.22.2 PRODUCTS & SERVICES
      14.22.3 FINANCIALS
      14.22.4 STRATEGY
      14.22.5 DEVELOPMENTS
  14.23 MASIMO CORPORATION
      14.23.1 OVERVIEW
      14.23.2 PRODUCTS & SERVICES
      14.23.3 FINANCIALS
      14.23.4 STRATEGY
      14.23.5 DEVELOPMENTS
  14.24 MINDRAY
      14.24.1 OVERVIEW
      14.24.2 PRODUCTS & SERVICES
      14.24.3 FINANCIALS
      14.24.4 STRATEGY
      14.24.5 DEVELOPMENTS
  14.25 MORTARA INSTRUMENT INC.
      14.25.1 OVERVIEW
      14.25.2 PRODUCTS & SERVICES
      14.25.3 FINANCIALS
      14.25.4 STRATEGY
      14.25.5 DEVELOPMENTS
  14.26 NATUS
      14.26.1 OVERVIEW
      14.26.2 PRODUCTS & SERVICES
      14.26.3 FINANCIALS
      14.26.4 STRATEGY
      14.26.5 DEVELOPMENTS
  14.27 NIHON KOHDEN
      14.27.1 OVERVIEW
      14.27.2 PRODUCTS & SERVICES
      14.27.3 FINANCIALS
      14.27.4 STRATEGY
      14.27.5 DEVELOPMENTS
  14.28 NONIN MEDICAL
      14.28.1 OVERVIEW
      14.28.2 PRODUCTS & SERVICES
      14.28.3 FINANCIALS
      14.28.4 STRATEGY
      14.28.5 DEVELOPMENTS
  14.29 OMRON
      14.29.1 OVERVIEW
      14.29.2 PRODUCTS & SERVICES
      14.29.3 FINANCIALS
      14.29.4 STRATEGY
      14.29.5 DEVELOPMENTS
  14.30 ORIDION
      14.30.1 OVERVIEW
      14.30.2 PRODUCTS & SERVICES
      14.30.3 FINANCIALS
      14.30.4 STRATEGY
      14.30.5 DEVELOPMENTS
  14.31 OSI SYSTEMS INC.
      14.31.1 OVERVIEW
      14.31.2 PRODUCTS & SERVICES
      14.31.3 FINANCIALS
      14.31.4 STRATEGY
      14.31.5 DEVELOPMENTS
  14.32 ROBERT BOSCH HEALTHCARE INC.
      14.32.1 OVERVIEW
      14.32.2 PRODUCTS & SERVICES
      14.32.3 FINANCIALS
      14.32.4 STRATEGY
      14.32.5 DEVELOPMENTS
  14.33 ROCHE DIAGNOSTICS LIMITED
      14.33.1 OVERVIEW
      14.33.2 PRODUCTS & SERVICES
      14.33.3 FINANCIALS
      14.33.4 STRATEGY
      14.33.5 DEVELOPMENTS
  14.34 ROYAL PHILIPS HEALTHCARE
      14.34.1 OVERVIEW
      14.34.2 PRODUCTS & SERVICES
      14.34.3 FINANCIALS
      14.34.4 STRATEGY
      14.34.5 DEVELOPMENTS
  14.35 SCHILLER AG
      14.35.1 OVERVIEW
      14.35.2 PRODUCTS & SERVICES
      14.35.3 FINANCIALS
      14.35.4 STRATEGY
      14.35.5 DEVELOPMENTS
  14.36 SECA GMBH & CO. KG.
      14.36.1 OVERVIEW
      14.36.2 PRODUCTS & SERVICES
      14.36.3 FINANCIALS
      14.36.4 STRATEGY
      14.36.5 DEVELOPMENTS
  14.37 SIEMENS HEALTHCARE
      14.37.1 OVERVIEW
      14.37.2 PRODUCTS & SERVICES
      14.37.3 FINANCIALS
      14.37.4 STRATEGY
      14.37.5 DEVELOPMENTS
  14.38 SMITHS MEDICAL
      14.38.1 OVERVIEW
      14.38.2 PRODUCTS & SERVICES
      14.38.3 FINANCIALS
      14.38.4 STRATEGY
      14.38.5 DEVELOPMENTS
  14.39 WELCH ALLYN
      14.39.1 OVERVIEW
      14.39.2 PRODUCTS & SERVICES
      14.39.3 FINANCIALS
      14.39.4 STRATEGY
      14.39.5 DEVELOPMENTS
  14.40 YOKOGAWA ELECTRIC CORPORATION
      14.40.1 OVERVIEW
      14.40.2 PRODUCTS & SERVICES
      14.40.3 FINANCIALS
      14.40.4 STRATEGY


 
LIST OF TABLES

TABLE 1 GLOBAL MARKET REVENUE, BY SEGMENTS ($MILLION)
TABLE 2 GLOBAL MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 3 MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 4 GLOBAL HEMODYNAMIC MONITORS MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 5 HEMODYNAMIC MONITORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 6 BLOOD PRESSURE MONITORS MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
TABLE 7 GLOBAL BLOOD PRESSURE MONITORS MARKET REVENUE, BY SITE OF USAGES, 2009 - 2016 ($MILLION)
TABLE 8 GLOBAL BLOOD PRESSURE MONITORS MARKET VOLUME, BY SITE OF USAGES, 2009 - 2016 (MILLION UNITS)
TABLE 9 BLOOD PRESSURE MONITORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 10 BLOOD PRESSURE MONITORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (MILLION UNITS)
TABLE 11 GLOBAL BLOOD PRESSURE MONITORS MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 12 GLOBAL BLOOD GLUCOSE MONITORS MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 13 GLOBAL BLOOD GLUCOSE MONITORS MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (MILLION UNITS)
TABLE 14 CONTINUOUS BLOOD GLUCOSE MONITOR MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 15 SINGLE-POINT BLOOD GLUCOSE MONITOR MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 16 BLOOD GLUCOSE MONITOR MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 17 BLOOD GLUCOSE MONITOR MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (MILLION UNITS)
TABLE 18 GLOBAL BLOOD GLUCOSE MONITORS MARKET REVENUE, BY END-USER, 2009 - 2016 ($MILLION)
TABLE 19 GLOBAL BLOOD GAS ANALYZERS MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 20 GLOBAL BLOOD GAS ANALYZERS MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (THOUSAND UNITS)
TABLE 21 GLOBAL BLOOD GAS ANALYZERS MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 22 POC BLOOD GAS ANALYZERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 23 POC BLOOD GAS ANALYZERS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 24 DESKTOP BLOOD GAS ANALYZERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 25 DESKTOP BLOOD GAS ANALYZERS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 26 BLOOD GAS ANALYZERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 27 GLOBAL BLOOD GAS ANALYZERS MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 28 CHOLESTEROL MONITORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 29 CHOLESTEROL MONITORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (MILLION UNITS)
TABLE 30 CHOLESTEROL MONITORS MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 31 GLOBAL NEUROMONITOR MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 32 NEUROMONITOR MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 33 EEG MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 34 EEG MARKET VOLUME, BY GEOGRAPHY, 2009 2016 (THOUSAND UNITS)
TABLE 35 GLOBAL EEG MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 36 TCD MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 37 TCD MARKET VOLUME, BY GEOGRAPHY, 2009 2016 (THOUSAND UNITS)
TABLE 38 GLOBAL TCD MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 39 MEG MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 40 MEG MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (NO. OF UNITS)
TABLE 41 GLOBAL MEG MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 42 GLOBAL CARDIAC MONITOR MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 43 CARDIAC MONITOR MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 44 GLOBAL ECG DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 45 GLOBAL ECG DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (THOUSAND UNITS)
TABLE 46 GLOBAL ECG DEVICES MARKET REVENUE, BY NO. OF LEADS, 2009 - 2016 ($MILLION)
TABLE 47 ECG DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 48 ECG DEVICES MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 49 GLOBAL ECG DEVICES MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 50 CARDIAC OUTPUT MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 51 CARDIAC OUTPUT MONITORING DEVICES MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 52 GLOBAL CARDIAC OUTPUT MONITORING DEVICES MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 53 FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 54 GLOBAL FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 55 GLOBAL FETAL & NEONATAL MONITORING DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (MILLION UNITS)
TABLE 56 GLOBAL FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 57 FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 58 FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 (VOLUME)
TABLE 59 INTERNAL FETAL MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 60 FETAL & NEONATAL INTRAUTERINE PRESSURE CATHETERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 61 FETAL & NEONATAL ULTRASOUND FETAL DOPPLERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 62 GLOBAL FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 63 GLOBAL RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 64 RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 65 GLOBAL CAPNOGRAPH MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 66 GLOBAL CAPNOGRAPH MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (THOUSAND UNITS)
TABLE 67 GLOBAL CAPNOGRAPH MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
TABLE 68 CAPNOGRAPH MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 69 CAPNOGRAPH MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 70 GLOBAL CAPNOGRAPH MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 71 GLOBAL SPIROMETER MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 72 GLOBAL SPIROMETER MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (THOUSAND UNITS)
TABLE 73 GLOBAL SPIROMETER MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
TABLE 74 SPIROMETER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 75 SPIROMETER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 76 GLOBAL SPIROMETER MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 77 GLOBAL ANAESTHESIA MONITOR MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 78 GLOBAL ANAESTHESIA MONITOR MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (THOUSAND UNITS)
TABLE 79 ANESTHESIA MONITOR MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 80 ANESTHESIA MONITOR MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 81 GLOBAL ANAESTHESIA MONITOR MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 82 GLOBAL SLEEP APNEA MONITORING DEVICE MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 83 GLOBAL SLEEP APNEA MONITORING DEVICE MARKET REVENUE, BY PRODUCTS, 2009 - 2016 (THOUSAND UNITS)
TABLE 84 SLEEP APNEA MONITORING DEVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 85 SLEEP APNEA MONITORING DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 86 GLOBAL SLEEP APNEA MONITORING DEVICE MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 87 GLOBAL PULSE OXIMETER MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 88 GLOBAL PULSE OXIMETER MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (THOUSAND UNITS)
TABLE 89 PULSE OXIMETER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 90 PULSE OXIMETER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 91 GLOBAL PULSE OXIMETER MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 92 GLOBAL MULTI-PARAMETER MARKET REVENUE, BY ACUITY, 2009 - 2016 ($MILLION)
TABLE 93 GLOBAL MULTI-PARAMETER MARKET VOLUME, BY ACUITY, 2009 - 2016 (THOUSAND UNITS)
TABLE 94 MULTI-PARAMETER HIGH ACUITY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 95 MULTI-PARAMETER MID ACUITY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 96 MULTI-PARAMETER LOW ACUITY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 97 MULTI-PARAMETER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 98 MULTI-PARAMETER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 99 GLOBAL MULTI-PARAMETER MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 100 REMOTE PATIENT MONITORING MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 101 GLOBAL REMOTE MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 102 GLOBAL OTHER MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 103 OTHER MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 104 GLOBAL WEIGHT MONITORING MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 105 GLOBAL WEIGHT MONITORING MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (THOUSAND UNITS)
TABLE 106 WEIGHT MONITORING MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 107 WEIGHT MONITORING MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 108 GLOBAL WEIGHT MONITORING MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 109 GLOBAL TEMPERATURE MONITORING MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 110 GLOBAL TEMPERATURE MONITORING MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (MILLION UNITS)
TABLE 111 TEMPERATURE MONITORING MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 112 TEMPERATURE MONITORING MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (MILLION UNITS)
TABLE 113 GLOBAL TEMPERATURE MONITORING MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 114 NORTH AMERICA: MARKET REVENUE, BY SEGMENTS, 2009 2016 ($MILLION)
TABLE 115 NORTH AMERICA: HEMODYNAMIC MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 116 NORTH AMERICA: NEUROMONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 117 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 118 NORTH AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 119 NORTH AMERICA: RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 120 NORTH AMERICA: MULTI-PARAMETER MONITORING DEVICES MARKET REVENUE, BY ACUITY, 2009 2016 ($MILLION)
TABLE 121 NORTH AMERICA OTHER MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 122 EUROPE: MARKET REVENUE, BY SEGMENTS, 2009 2016 ($MILLION)
TABLE 123 EUROPE: HEMODYNAMIC MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 124 EUROPE: NEUROMONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 125 EUROPE: CARDIAC MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 126 EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 127 EUROPE: RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 128 EUROPE: MULTI-PARAMETER MONITORING DEVICES MARKET REVENUE, BY ACUITY, 2009 2016 ($MILLION)
TABLE 129 EUROPE: OTHER MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 130 APAC: PATIENT HEALTHCARE MONITORING DEVICES MARKET REVENUE, BY SEGMENTS, 2009 2016 ($MILLION)
TABLE 131 APAC: HEMODYNAMIC PATIENT MONITORING MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 132 APAC: NEUROMONITORING MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 133 APAC: CARDIAC MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 134 APAC: FETAL & NEONATAL MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 135 APAC: RESPIRATORY MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 136 APAC: MULTI-PARAMETER MARKET REVENUE, BY ACUITY, 2009 2016 ($MILLION)
TABLE 137 APAC: OTHER MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 138 ROW: PATIENT HEALTHCARE MONITORING DEVICES MARKET REVENUE, BY SEGMENTS, 2009 2016 ($MILLION)
TABLE 139 ROW: HEMODYNAMIC MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 140 ROW: NEUROMONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 141 ROW: CARDIAC MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 142 ROW: FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 143 ROW: RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 144 ROW: MULTI-PARAMETER MONITORING DEVICES MARKET REVENUE, BY ACUITY, 2009 2016 ($MILLION)
TABLE 145 ROW: OTHER MARKET REVENUE, BY PRODUCTS, 2009 2016 ($MILLION)
TABLE 146 MERGERS & ACQUISITIONS, JANUARY 2009 MARCH 2012
TABLE 147 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES, JANUARY, 2009 APRIL 2012
TABLE 148 NEW PRODUCTS LAUNCH, JANUARY 2009 MARCH 2012
TABLE 149 OTHER DEVELOPMENTS, JANUARY 2009 MARCH 2012
TABLE 150 A & D COMPANY LTD.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 151 A & D COMPANY LTD.: TOTAL REVENUE, BY SEGMENTS, 2009 2011 ($MILLION)
TABLE 152 A&D COMPANY LTD: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 153 ABBOTT LABORATORIES: NET SALES AND R&D EXPENDITURE, 2008 2010 ($BILLION)
TABLE 154 ABBOTT LABORATORIES: NET SALES, BY SEGMENTS, 2008 2010 ($MILLION)
TABLE 155 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, 2008 2010 ($MILLION)
TABLE 156 AMBU: NET SALES AND R&D EXPENDITURE, 2008 2010 ($BILLION)
TABLE 157 AMBU: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011($MILLION)
TABLE 158 AMBU: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011($MILLION)
TABLE 159 CARDIONET INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 160 CARDIONET INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 161 CAREFUSION: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 162 CAREFUSION: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 163 CAREFUSION: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 164 COMPUMEDICS: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011($MILLION)
TABLE 165 COMPUMEDICS: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 166 COMPUMEDICS: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 167 CONMED: NET SALES AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 168 CONMED: NET SALES, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 169 CONMED: NET SALES, BY GEOGRAPHY, 2008 2010 ($MILLION)
TABLE 170 COVIDIEN: NET SALES AND R&D EXPENSES, 2009 - 2011($MILLION)
TABLE 171 COVIDIEN: NET SALES, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 172 COVIDIEN: NET SALES, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 173 DRAEGER: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 174 DRAEGER: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 175 EDWARDS LIFESCIENCES: NET SALES AND R&D EXPENSES, 2008 2010 ($MILLION)
TABLE 176 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009-2011 ($MILLION)
TABLE 177 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 178 ELEKTA: TOTAL REVENUE AND R&D EXPENSES, 2008-2010 ($MILLION)
TABLE 179 ELEKTA: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010 ($MILLION)
TABLE 180 FISHER & PAYKEL HEALTHCARE: TOTAL OPERATING REVENUE AND R&D EXPENSES, 2009 - 2011($MILLION)
TABLE 181 FISHER & PAYKEL HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 182 FISHER & PAYKEL HEALTHCARE: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 183 FUKUDA DENSHI COMPANY LTD.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 184 FUKUDA DENSHI COMPANY LTD.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 185 GE HEALTHCARE: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011($BILLION)
TABLE 186 GE HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($BILLION)
TABLE 187 GE HEALTHCARE: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 188 HONEYWELL INTERNATIONAL INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 189 HONEYWELL INTERNATIONAL INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 190 HONEYWELL INTERNATIONAL INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 191 JOHNSON & JOHNSON INC.: TOTAL SALES AND R&D EXPENSES, 2009 - 2011 ($BILLION)
TABLE 192 JOHNSON & JOHNSON INC.: R&D EXPENDITURE, BY SEGMENTS, 2009 - 2011 ($BILLION)
TABLE 193 JOHNSON & JOHNSON INC.: TOTAL SALES, BY SEGMENTS, 2009 - 2011 ($BILLION)
TABLE 194 JOHNSON & JOHNSON INC.: TOTAL SALES, BY GEOGRAPHY, 2009 - 2011 ($BILLION)
TABLE 195 LARSEN & TOUBRO LTD.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2010 ($MILLION)
TABLE 196 LARSEN & TOUBRO LTD.: TOTAL REVENUE, BY SEGMENTS ($MILLION)
TABLE 197 LARSEN & TOUBRO LTD.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 198 LIFEWATCH AG: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 199 LIFEWATCH AG: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 200 LIFEWATCH AG: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 201 MASIMO: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($THOUSAND)
TABLE 202 MINDRAY: TOTAL REVENUE AND R&D EXPENSES, 2008 2010 ($THOUSAND)
TABLE 203 MINDRAY: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010 ($THOUSAND)
TABLE 204 MINDRAY: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($THOUSAND)
TABLE 205 NATUS: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 206 NATUS: TOTAL REVENUE, BY SEGMENTS, 2008 - 2011 ($MILLION)
TABLE 207 NIHON KOHDEN: NET SALES AND R&D EXPENSES, 2009 - 2011 ($THOUSAND)
TABLE 208  NIHON KOHDEN: NET SALES, BY SEGMENTS, 2009 - 2011 ($THOUSAND)
TABLE 209 NIHON KOHDEN: NET SALES, BY GEOGRAPHY, 2009 - 2011 ($THOUSAND)
TABLE 210 OMRON: NET SALES AND R&D EXPENSES, 2008 - 2010 ($MILLION)
TABLE 211 OMRON: NET SALES, BY SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 212 ORIDION: NET REVENUE AND R&D EXPENSES, 2009 2011($MILLION)
TABLE 213 ORIDION: NET REVENUE, BY GEOGRAPHY, 2009 - 2011($MILLION)
TABLE 214 OSI SYSTEMS INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 215 OSI SYSTEMS INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 216 OSI SYSTEMS INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 217 BOSCH GROUP: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 218 BOSCH GROUP : TOTAL REVENUE, BY SEGMENTS ($MILLION)
TABLE 219 BOSCH GROUP : TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2011 ($MILLION)
TABLE 220 ROCHE: TOTAL REVENUE AND R&D EXPENSES, 2009 2011 ($MILLION)
TABLE 221 ROYAL PHILIPS HEALTHCARE: COMPANY SALES AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 222 ROYAL PHILIPS HEALTHCARE: BUSINESS DIVISION SALES, 2009 - 2011 ($MILLION)
TABLE 223 ROYAL PHILIPS HEALTHCARE: SEGMENT SALES, 2009-2011 ($MILLION)
TABLE 224 SIEMENS: TOTAL REVENUE AND R&D EXPENSES, 2009 2011 ($MILLION)
TABLE 225 SIEMENS: TOTAL REVENUE, BY SEGMENTS, 2009 2011 ($MILLION)
TABLE 226 SIEMENS: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 227 SMITHS MEDICAL: TOTAL SALES AND R&D EXPENSES, 2009 2011 ($MILLION)
TABLE 228 SMITHS MEDICAL: TOTAL SALES, BY SEGMENTS, 2009 2011 ($MILLION)
TABLE 229 YOKOGAWA ELECTRIC CORP: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 230 YOKOGAWA ELECTRIC CORP: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 231 YOKOGAWA ELECTRIC CORP: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)


 
LIST OF FIGURES


FIGURE 1 BUBBLE CHART OF MARKET, BY SEGMENTS, 2011 ($MILLION)
FIGURE 2 MARKET, BY GEOGRAPHY, 2009 2016 ($MILLION)
FIGURE 3 MARKET DYNAMICS
FIGURE 4 MARKET SEGMENTATION OF PATIENT MONITORING DEVICES
FIGURE 5 MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2010
FIGURE 6 MARKET SHARE ANALYSIS - BLOOD PRESSURE MONITOR, 2010
FIGURE 7 MARKET SHARE ANALYSIS - SINGLE POINT BLOOD GLUCOSE MONITOR, 2010
FIGURE 8 MARKET SHARE ANALYSIS - CONTINUOUS BLOOD GLUCOSE MONITOR, 2010
FIGURE 9 MARKET SHARE ANALYSIS - BLOOD GAS ANALYZERS, 2010
FIGURE 10 MARKET SHARE ANALYSIS NEUROMONITORS, 2010
FIGURE 11 MARKET SHARE ANALYSIS EEG, 2010
FIGURE 12 MARKET SHARE ANALYSIS TCD, 2010
FIGURE 13 MARKET SHARE ANALYSIS MEG, 2010
FIGURE 14 MARKET SHARE ANALYSIS CARDIAC MONITORS, 2010
FIGURE 15 MARKET SHARE ANALYSIS ECG, 2010
FIGURE 16 MARKET SHARE ANALYSIS RESPIRATORY MONITORS, 2010
FIGURE 17 MARKET SHARE ANALYSIS CAPNOGRAPH, 2010
FIGURE 18 MARKET SHARE ANALYSIS SPIROMETER, 2010
FIGURE 19 MARKET SHARE ANALYSIS ANESTHESIA MONITOR, 2010
FIGURE 20 MARKET SHARE ANALYSIS - SLEEP APNEA MONITOR, 2010
FIGURE 21 MARKET SHARE ANALYSIS - PULSE OXIMETER, 2010
FIGURE 22 MARKET SHARE ANALYSIS FETAL & NEONATAL MONITORS , 2010
FIGURE 23 MARKET SHARE ANALYSIS - MULTI-PARAMETER MONITOR, 2010
FIGURE 24 MARKET SHARE ANALYSIS REMOTE PATIENT MONITORING DEVICES, 2010
FIGURE 25 END-USER ANALYSIS PATIENT MONITORING DEVICES , 2010
FIGURE 26 MARKET SEGMENTATION OF HEMODYNAMIC MONITORING DEVICES
FIGURE 27 MARKET SEGMENTATION OF NEUROLOGICAL MONITORING DEVICES
FIGURE 28 MARKET SEGMENTATION OF CARDIAC MONITORING DEVICES
FIGURE 29 MARKET SEGMENTATION OF FETAL & NEONATAL MONITORING DEVICES
FIGURE 30 MARKET SEGMENTATION OF RESPIRATORY MONITORING DEVICES
FIGURE 31 MARKET SEGMENTATION OF MULTI-PARAMETER MONITORING DEVICES
FIGURE 32 MARKET SEGMENTATION OF OTHER MONITORING DEVICES
FIGURE 33 KEY GROWTH STRATEGIES, JANUARY 2009 - MARCH 2012
FIGURE 34 COMPETITVE MAPPING (HEAT MAP)

Over the years patient monitoring has evolved greatly by decreasing size of devices, increasing utility, sensitivity, and performance. Visible growing trends of wireless devices have created a surge in growth. Patients adopting wireless devices have increased due to ease of usability and portability of devices. These monitoring devices can be transported from hospital to home, have longer battery duration and larger memory storage. Current monitors are highly adaptable both for hospital and home monitoring as most patients insist on hospital grade devices at home. Remote patient monitoring inspite of being a nascent area, still progresses due to strict government regulations charging penalties on hospitals for frequent re-admission of patients.

The global patient monitoring devices market was valued at $14.2 billion in the year 2011 and is expected to grow at a CAGR of 5.9% from 2011 to 2016 to reach $18.9 billion.

Hemodynamics is a major segment in the patient monitoring devices market. It includes products like blood pressure monitors, blood glucose monitors, blood gas analyzers and blood cholesterol monitors. It commands a share of more than 26% to the global patient monitors market.

Patient Monitoring Systems Market, Patient Monitoring Devices Market, Patient Monitoring Equipments Market, Healthcare Monitoring Devices Market

Source: MarketsandMarkets

The hemodynamic market has revenue of $3.7 billion and growing at a CAGR of 4.9%. The market is driven by increase in hypertension cases and diabetic population.

The major players in the hemodynamic monitoring devices are Omron (Japan), Roche (Switzerland), Abbott (U.S.), Bayer (U.S.) and Johnson&Johnson (U.S.). Omron leads the BP monitor market, while blood gas monitoring devices market is dominated by Roche. Roche also has the largest share in the single point blood glucose monitors, while Medtronic takes a major share in the continuous blood glucose monitor market.

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports